Yvonne Schrage

1.6k total citations
52 papers, 820 citations indexed

About

Yvonne Schrage is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Yvonne Schrage has authored 52 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 12 papers in Rheumatology. Recurrent topics in Yvonne Schrage's work include Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Vascular Tumors and Angiosarcomas (9 papers). Yvonne Schrage is often cited by papers focused on Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Vascular Tumors and Angiosarcomas (9 papers). Yvonne Schrage collaborates with scholars based in Netherlands, United States and United Kingdom. Yvonne Schrage's co-authors include Judith V.M.G. Bovée, Pancras C.W. Hogendoorn, Antonïe H.M. Taminiau, A. H. M. Taminiau, D. Eefting, Winan J. van Houdt, Saskia le Cessie, Maartje J. A. Geirnaerdt, Inge H. Briaire‐de Bruijn and Károly Szuhai and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Yvonne Schrage

48 papers receiving 812 citations

Peers

Countries citing papers authored by Yvonne Schrage

Since Specialization

Citations

This map shows the geographic impact of Yvonne Schrage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Schrage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Schrage more than expected).

Fields of papers citing papers by Yvonne Schrage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Schrage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Schrage. The network helps show where Yvonne Schrage may publish in the future.

Co-authorship network of co-authors of Yvonne Schrage

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Schrage. A scholar is included among the top collaborators of Yvonne Schrage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Schrage. Yvonne Schrage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Prediagnostic General Practitioners’ Pathway of Gastrointestinal Stromal Tumor Patients: A Real-World Data Study 2025 ·Cancers ·(unknown), (unknown), Winette T.A. van der Graaf, (unknown), Winan J. van Houdt, Yvonne Schrage, Tim olde Hartman, Annemarie Uijen, Neeltje Steeghs, (unknown), M. Heins, Olga Husson	0
2	The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma 2025 ·ESMO Open ·P. van der Laan, Winan J. van Houdt, Hester van Boven, Pétur Snæbjörnsson, Linda J.W. Bosch, Kim Monkhorst, Yvonne Schrage, L. Heimans, J. Martijn Kerst, Neeltje Steeghs, Winette T.A. van der Graaf	1
3	Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST 2025 ·Cancers ·(unknown), Evelyne Roets, (unknown), (unknown), Dirk J. Grünhagen, Ingrid M.E. Desar, Han J. Bonenkamp, Anna K.L. Reyners, Boudewijn van Etten, Henk H. Hartgrink, Marta Fiocco, Yvonne Schrage, Neeltje Steeghs, Hans Gelderblom	1
4	Reconsidering the surgical approach in cutaneous melanoma: does wide local excision after a complete diagnostic excision reduce the risk of recurrence? 2025 ·European Journal of Cancer ·(unknown), (unknown), Remco van Doorn, Annemiek Doeksen, Willeke A.M. Blokx, Yvonne Schrage, (unknown), Richard A. Scolyer, Emily L. Postma, (unknown)	1
5	Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma: An addition for existing risk classification systems? 2024 ·European Journal of Surgical Oncology ·P.H. van der Laan, Winette T.A. van der Graaf, Daan van den Broek, Hester van Boven, (unknown), Yvonne Schrage, Rick L. Haas, Neeltje Steeghs, Winan J. van Houdt	1
6	Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study 2024 ·The Breast ·(unknown), Sophie J. M. Reijers, Anke Kuijpers, L. Heimans, Astrid N. Scholten, (unknown), Hester van Boven, (unknown), Marie-Jeanne T. F. D. Vrancken Peeters, Martijn Kerst, (unknown), Neeltje Steeghs, Winette T.A. van der Graaf, Yvonne Schrage, Winan J. van Houdt	2
7	Magnetic seed localization is feasible for non-palpable melanoma, Merkel cell carcinoma, and soft tissue sarcoma lesions 2024 ·European Journal of Surgical Oncology ·(unknown), A. Kuijpers, (unknown), Alexander C. J. van Akkooi, Sophie J. M. Reijers, Michel W.J.M. Wouters, Yvonne Schrage, Winan J. van Houdt	2
8	Elevated preoperative serum interleukin-6 level is predictive for worse postoperative outcome after soft tissue sarcoma surgery 2023 ·European Journal of Surgical Oncology ·P.H. van der Laan, Winette T.A. van der Graaf, Sophie J. M. Reijers, Yvonne Schrage, (unknown), Rick L. Haas, Diane van den Broek, Neeltje Steeghs, Winan J. van Houdt	2
9	Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma 2023 ·Acta Oncologica ·Sophie J. M. Reijers, Nicolò Gennaro, Annemarie Bruining, Hester van Boven, Pétur Snæbjörnsson, Elise M. Bekers, Frits van Coevorden, Astrid N. Scholten, Yvonne Schrage, Winette T.A. van der Graaf, Rick L. Haas, Winan J. van Houdt	7
10	Standards in surgical training in advanced pelvic malignancy across Europe and beyond – A Snapshot analysis 2022 ·European Journal of Surgical Oncology ·Andreas Brandl, Dara Lundon, Laura Lorenzon, Yvonne Schrage, Carmela Caballero, (unknown), (unknown), (unknown), Giacomo Montagna, Olivia Sgarbură, Raza Sayyed, Almog Ben‐Yaacov, (unknown), (unknown), Helen Mohan, Tibor Kovács, Domenico D’Ugo, Sergio Sandrucci, Wim Ceelen	1
11	Incidence of unplanned excisions of soft tissue sarcomas in the Netherlands: A population-based study 2021 ·European Journal of Surgical Oncology ·(unknown), Melissa Vos, Melinda S. Schuurman, Thijs van Dalen, Winan J. van Houdt, Jos A. van der Hage, Yvonne Schrage, Lukas B. Been, (unknown), Marc H.A. Bemelmans, Dirk J. Grünhagen, Cornelis Verhoef, Vincent K.Y. Ho	16
12	Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study 2021 ·European Journal of Surgical Oncology ·(unknown), Nikki S. IJzerman, Peter Hohenberger, Piotr Rutkowski, Robin L. Jones, Javier Martín‐Broto, Alessandro Gronchi, Patrick Schöffski, Nikolaos Vassos, Sheima Farag, Marco Baia, (unknown), Neeltje Steeghs, Ingrid M.E. Desar, A.K.L. Reyners, J.W. van Sandick, Esther Bastiaannet, Hans Gelderblom, Yvonne Schrage	7
13	Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas 2021 ·Radiotherapy and Oncology ·(unknown), Winan J. van Houdt, Kirsten van Langevelde, Piet L.A. van den Ende, Winette T.A. van der Graaf, Yvonne Schrage, Hester van Boven, Astrid N. Scholten, Rick L. Haas	4
14	Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms 2021 ·European Journal of Cancer ·Dario Callegaro, Francesco Barretta, Carol J. Swallow, D. Strauß, Sylvie Bonvalot, Charles Honoré, Eberhard Stoeckle, Frits van Coevorden, Rick L. Haas, Piotr Rutkowski, Yvonne Schrage, Mark Fairweather, Lorenzo Conti, Nikolaos Vassos, Rebecca A. Gladdy, Deanna Ng, Winan J. van Houdt, Rosalba Miceli, Chandrajit P. Raut, Alessandro Gronchi	14
15	A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma 2021 ·European Journal of Surgical Oncology ·(unknown), Pètra M. Braam, Erik van Werkhoven, Astrid N. Scholten, Yvonne Schrage, Winan J. van Houdt, Kirsten van Langevelde, Rick L. Haas	10
16	Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly 2021 ·European Journal of Surgical Oncology ·(unknown), (unknown), Veroniek M. van Praag, Desirée M. J. Dorleijn, Cornelis Verhoef, Yvonne Schrage, Rick L. Haas, Michiel A. J. van de Sande, Han J. Bonenkamp, Robert J. van Ginkel, Dirk J. Grünhagen, Lee Jeys, Johnny Keller, Emelie Styring, Joanna Szkandera, Olga Zaikova	4
17	Neoadjuvant Systemic Treatment of Primary Angiosarcoma 2020 ·Cancers ·Kimberley M. Heinhuis, Nikki S. IJzerman, Winette T.A. van der Graaf, J. Martijn Kerst, Yvonne Schrage, Jos H. Beijnen, Neeltje Steeghs, Winan J. van Houdt	26
18	The use of FDG‐PET/CT to detect early recurrence after resection of high‐risk stage III melanoma 2020 ·Journal of Surgical Oncology ·(unknown), Bernies van der Hiel, Marcel P. M. Stokkel, Yvonne Schrage, Winan J. van Houdt, Michel W.J.M. Wouters, Alexander C. J. van Akkooi	5
19	Surgical management of metastatic gastrointestinal stromal tumour 2018 ·European Journal of Surgical Oncology ·Yvonne Schrage, Henk H. Hartgrink, Myles Smith, Marco Fiore, Piotr Rutkowski, Dimitri Tzanis, Christina Messiou, Vincent Servois, Sylvie Bonvalot, Jos A. van der Hage	8
20	Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment 2009 ·Cancer Research ·Yvonne Schrage, Inge H. Briaire‐de Bruijn, Noel F.C.C. de Miranda, Jolieke G. van Oosterwijk, Antonïe H.M. Taminiau, Tom van Wezel, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact